Skip to main content
Oxidative Medicine and Cellular Longevity logoLink to Oxidative Medicine and Cellular Longevity
. 2018 May 22;2018:6091947. doi: 10.1155/2018/6091947

Corrigendum to “Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes”

Yoko Fuyuno 1,, Hiroshi Uchi 1, Mao Yasumatsu 2, Saori Morino-Koga 3, Yuka Tanaka 2, Chikage Mitoma 1,2, Masutaka Furue 1,2
PMCID: PMC5987232  PMID: 29951165

In the article titled “Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes” [1], there was an error in Supplementary Figure S3. The figure incorrectly showed that PAH induced ROS expression and BaP suppressed ROS expression induced by PAH, whereas the corrected figure shows that BaP induced ROS expression and PAH suppressed ROS expression induced by BaP. The correct supplementary figure is available here.

Supplementary Materials

Supplementary Materials

Supplementary 3. Figure S3: flow cytometric analysis of ROS confirmed the inhibitory action of PAH against BaP-induced ROS generation. ∗∗ p < 0 01.

References

  • 1.Fuyuno Y., Uchi H., Yasumatsu M., et al. Perillaldehyde inhibits AHR signaling and activates NRF2 antioxidant pathway in human keratinocytes. Oxidative Medicine and Cellular Longevity. 2018;2018:9. doi: 10.1155/2018/9524657.9524657 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Materials

Supplementary 3. Figure S3: flow cytometric analysis of ROS confirmed the inhibitory action of PAH against BaP-induced ROS generation. ∗∗ p < 0 01.


Articles from Oxidative Medicine and Cellular Longevity are provided here courtesy of Wiley

RESOURCES